The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter analysis of melanoma recurrence pattern and management after adjuvant immunotherapy.
 
Sergio Martínez Recio
Honoraria - Ipsen; Pierre Fabre; Sanofi
 
Maria Alejandra Molina
No Relationships to Disclose
 
Eva Muñoz-Couselo
Honoraria - BMS; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; MSD; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Bristol-Myers Squibb/Celgene; MSD; Novartis; Pierre Fabre; Sanofi
 
Alberto Rafael Sevillano Tripero
No Relationships to Disclose
 
Juan Martin-Liberal
Consulting or Advisory Role - Bristol-Myers Squibb; Highlight Therapeutics; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD; Novartis; Pfizer; Pierre Fabre; Roche
 
Mayra Orrillo
No Relationships to Disclose
 
Luis Antonio Fernandez
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre
Consulting or Advisory Role - Novartis; Pfizer
 
Maria Quindós Varela
Honoraria - Bristol Myers Squibb Foundation; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Sanofi
 
Rocio Lesta
Honoraria - ROVI; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Merck Sharp & Dohme; Pierre Fabre; Roche
 
Andrés Barba
Speakers' Bureau - Angelini; BMS; MSD; Roche
Travel, Accommodations, Expenses - BMS; BMS; MSD; Pierre Fabre; Pierre Fabre; Roche
 
Ivana Sullivan
Consulting or Advisory Role - Boehringer Ingelheim; Novartis; Roche; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Pfizer; Roche; Takeda
 
Margarita Majem
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Helsinn Therapeutics; Janssen Oncology; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); BMS (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Roche